On March 30th, 2021, Horizon Therapeutics announced in a press release that it will begin resupplying the market with its biologic therapy TEPEZZA beginning in April 2021, after a temporary nationwide shortage.
IVX Health is now accepting new TEPEZZA patients.
Healthcare providers have not yet received formal notice as to when they will be able to procure the therapy or at what volume, and IVX Health is continuing to monitor the situation closely. Our organization is cautiously optimistic that patient appointments will begin soon and will proactively communicate with patients and referring providers as more information becomes available.
For new patients interested in seeking treatment, please complete our online form.
For existing patients inquiring about restarting an existing regimen, please contact your IVX Health local center.